Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.4K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K
Stimulants01:29

Stimulants

1.3K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.3K
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

599
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
599
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.6K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.6K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Operationalization drift in the construct of impulsivity: relevance to animal models of addiction.

Translational psychiatry·2026
Same author

Lost in translation-what is translational neuroscience research?

Brain communications·2026
Same author

Longitudinal Tracking of Astrocyte Reactivity During the Development of Chronic Orofacial Neuropathic Pain Using [<sup>18</sup>F]-SMBT-1 Positron-Emission Tomography.

Glia·2026
Same author

Psilocybin restores behavior and 5-HT<sub>2A</sub> signaling while reducing microglial density after chronic traumatic brain injury in rats.

Cell reports. Medicine·2026
Same author

Celebrating the founding editor of <i>Brain Communications</i>: Tara Spires-Jones.

Brain communications·2026
Same author

Cortical similarity networks in the rat brain: Postnatal development and sensitivity to early life stress.

Network neuroscience (Cambridge, Mass.)·2026

Related Experiment Video

Updated: Apr 21, 2026

A Conflict Model of Reward-seeking Behavior in Male Rats
06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

6.8K

Endocannabinoids and striatal function: implications for addiction-related behaviours.

Fabricio A Moreira1, Bianca Jupp, David Belin

  • 1aDepartment of Pharmacology, Institute of Biological Science, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil Departments of bPsychology cPharmacology, University of Cambridge dDepartment of Psychiatry, Addenbrookes's Hospital University of Cambridge, Cambridge, UK.

Behavioural Pharmacology
|November 6, 2014
PubMed
Summary

Targeting the endocannabinoid system shows promise for addiction treatment. Cannabinoid agents can modulate impulsivity and anxiety, potentially aiding rehabilitation from drug use.

More Related Videos

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
10:05

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior

Published on: September 16, 2015

15.8K
Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
09:43

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

2.6K

Related Experiment Videos

Last Updated: Apr 21, 2026

A Conflict Model of Reward-seeking Behavior in Male Rats
06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

6.8K
Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
10:05

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior

Published on: September 16, 2015

15.8K
Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
09:43

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

2.6K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • The endocannabinoid system, involving anandamide and 2-arachidonoyl glycerol, is implicated in addiction.
  • Cannabinoid CB1 receptor antagonists reduce drug-seeking behavior in rodents.
  • Endocannabinoid system modulation may treat addiction by addressing impulsivity and anxiety.

Purpose of the Study:

  • To review rodent studies on cannabinoid agents' effects on impulsivity and anxiety.
  • To explore the potential of targeting endocannabinoid metabolism for addiction treatment.
  • To discuss novel mechanisms for modulating the endocannabinoid system in addiction.

Main Methods:

  • Review of recent rodent research findings.
  • Pharmacological modulation of cannabinoid receptors (CB1, CB2).
  • Inhibition of endocannabinoid metabolism (FAAH, MAGL).

Main Results:

  • Cannabinoid CB1 antagonists/inverse agonists decrease reinstatement of drug-seeking behavior.
  • Selective inhibitors of endocannabinoid metabolism reduce anxiety and stress.
  • Selective CB2 receptor agonists attenuate impulsivity, anxiety, and drug reward.

Conclusions:

  • Cannabinoid agents offer potential therapeutic strategies for addiction.
  • Targeting endocannabinoid metabolism and CB2 receptors may ameliorate addiction-related traits.
  • Further research into these mechanisms could advance addiction treatment.